NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y14.96% Total Holdings177 Perf Week2.05%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y26.97% AUM443.30M Perf Month6.41%
Fund Family Bond Type Tagstechnology Return% 5Y15.80% NAV/sh Perf Quarter16.82%
IndexNYSE FactSet U.S.Tech Breakthrough Indx Average Maturity Tagsgenomics Return% 10Y 52W High57.37 0.92% Perf Half Y8.00%
Index Weighting Commodity Type TagsA.I. Return% SI 52W Low41.69 38.87% Perf YTD8.85%
Active/Passive Quant Type Tagsrobotics Flows% 1M-1.22% Volatility0.81% 0.92% Perf Year14.62%
Dividend TTM0.20 (0.34%) ESG Type Tagsinnovation Flows% 3M-1.87% ATR (14)0.70 Perf 3Y102.57%
Dividend Ex-DateJun 16, 2025 Dividend Type Sector/Theme Flows% YTD-6.23% RSI (14)71.45 Perf 5Y104.33%
Dividend Gr. 3/5Y8.35% - Structure Type Region Flows% 1Y Beta1.18 Perf 10Y-
Expense0.30% Growth/Value SMA203.59% Flows% 3Y Rel Volume0.33 Prev Close57.26
Inverse/Leveraged Market Cap SMA507.71% Flows% 5Y Avg Volume29.60K Price57.90
IPOJan 13, 2020 Option/ShortYes / Yes SMA2009.54% Trades Volume9,647 Change1.11%
Apr-30-25 09:10AM
Apr-29-25 01:23PM
08:35AM
Apr-25-25 07:40AM
Apr-23-25 07:46AM
03:45AM Loading…
Apr-16-25 03:45AM
03:20AM
Apr-15-25 08:20AM
Apr-07-25 07:46AM
Apr-03-25 08:25PM
Apr-01-25 01:15AM
Mar-20-25 02:25AM
Sep-02-21 12:00PM
iShares U.S. Tech Breakthrough Multisector ETF seeks to track the investment results of the NYSE FactSet U.S. Tech Breakthrough IndexTM. The underlying index measures the performance of U.S. listed companies engaged in cutting edge research and development of products and services in the areas of robotics and artificial intelligence, cyber security, cloud and data tech, financial technology, and genomics and immunology. It generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The fund is non-diversified.